Kura Oncology, Inc.KURANASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P36
Within normal range
vs 3Y Ago
-2x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -7.84% |
| Q3 2025 | -10.09% |
| Q2 2025 | -12.31% |
| Q1 2025 | -188.13% |
| Q4 2024 | 62.50% |
| Q3 2024 | -6.17% |
| Q2 2024 | -3.58% |
| Q1 2024 | -16.44% |
| Q4 2023 | -10.10% |
| Q3 2023 | -6.17% |
| Q2 2023 | -9.40% |
| Q1 2023 | -4.01% |
| Q4 2022 | 3.93% |
| Q3 2022 | -3.57% |
| Q2 2022 | -7.78% |
| Q1 2022 | 0.77% |
| Q4 2021 | 1.90% |
| Q3 2021 | -0.09% |
| Q2 2021 | -8.90% |
| Q1 2021 | -17.33% |
| Q4 2020 | -8.84% |
| Q3 2020 | -14.27% |
| Q2 2020 | -4.82% |
| Q1 2020 | -6.52% |
| Q4 2019 | -7.29% |
| Q3 2019 | -11.22% |
| Q2 2019 | -6.29% |
| Q1 2019 | 10.12% |
| Q4 2018 | -4.08% |
| Q3 2018 | -4.62% |
| Q2 2018 | -1.90% |
| Q1 2018 | -36.34% |
| Q4 2017 | -15.75% |
| Q3 2017 | -19.79% |
| Q2 2017 | -3.62% |
| Q1 2017 | -2.34% |
| Q4 2016 | -5.95% |
| Q3 2016 | -3.93% |
| Q2 2016 | 3.54% |
| Q1 2016 | -2.89% |